Adding Bevacizumab Ineffective in AngiosarcomaAdding Bevacizumab Ineffective in Angiosarcoma

Bevacizumab plus weekly paclitaxel did not improve outcomes in advanced angiosarcoma. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news